Live from the NIH registry
Studies recruiting near Tulsa right now
Top 25 of 173 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Treatment Centers of America — Tulsa, Oklahoma (5.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Genentech, Inc.
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Intracerebral Hemorrhage
Phase 3
Interventional 350 participants sought
St. John Medical Center — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Joseph Broderick, MD
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Edwards Lifesciences
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 0041) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The Movement Disorder Clinic of Oklahoma — Tulsa, Oklahoma (5.3 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Tulsa Retina Consultants — Tulsa, Oklahoma (5.3 mi)
· Sponsor: EyeBiotech Ltd.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Ganglioneuroblastoma, Nodular, Neuroblastoma
Phase 3
Interventional 478 participants sought
Saint Francis Children's Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: National Cancer Institute (NCI)
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Breast Cancer, Lymphoma
EARLY/Phase 1
Interventional 104 participants sought
Stephenson Cancer Center- Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Local Institution - 0052 — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Bristol-Myers Squibb
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
DelRicht Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Kallyope Inc.
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Mantle Cell Lymphoma
Phase 3
Interventional 421 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Phase 3
Interventional 1,023 participants sought
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001) — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure
Heart Failure With Reduced Ejection Fraction
N/A
Interventional 270 participants sought
Saint Francis Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: VisCardia Inc.
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Phase 3
Interventional 70 participants sought
Urologic Specialists of Oklahoma — Tulsa, Oklahoma (5.3 mi)
· Sponsor: UroGen Pharma Ltd.
Reset Challenge: Reducing High-risk Drinking for Cancer Prevention
Alcohol Drinking, Heavy Drinking
N/A
Interventional 150 participants sought
University of Oklahoma Schusterman Center - Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma
Evaluation of a Keto-Like Supplement on Brain Responses to Emotional Stimuli in Depression
Depression
Phase 2
Interventional 75 participants sought
Laureate Institute for Brain Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Laureate Institute for Brain Research, Inc.
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
Saint Francis Hospital — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Abiomed Inc.
xDot Access Management System Early Feasibility Study
Vascular Closure Devices
N/A
Interventional 30 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: xDot Medical, Inc
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Nectero Medical, Inc.
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
DelRicht Research — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Eli Lilly and Company
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Persistent Atrial Fibrillation
N/A
Interventional 376 participants sought
Oklahoma Heart Institute — Tulsa, Oklahoma (5.3 mi)
· Sponsor: Boston Scientific Corporation
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Oklahoma Cancer Specialists and Research Institute-Tulsa — Tulsa, Oklahoma (5.3 mi)
· Sponsor: NRG Oncology
Oklahoma Study of Native American Pain Risk III: Stress and Resilience
Discrimination, Racial, Stress Physiology
N/A
Observational 220 participants sought
University of Oklahoma - Schusterman Center — Tulsa, Oklahoma (5.3 mi)
· Sponsor: University of Oklahoma